EUVIMEDEUVIMED entdecken
Crossref

Late‐Stage Halogenation of Peptides, Drugs and (Hetero)aromatic Compounds with a Nucleophilic Hydrazide Catalyst

Haripriyo Mondal iD, Subimal Patra, Shuvendu Saha, Tarak Nayak, Uddalak Sengupta, Modhu Sudan Maji iD

Angewandte Chemie International Edition · 18.12.2023 · 62 (51)

DOI: 10.1002/anie.202312597 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, online erschienen am 20.11.2023. Verfasst von Haripriyo Mondal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Indian Institute of Technology Kharagpur, Kharagpur, 721302, India. Hauptthemen laut MEDLINE: Halogenation, Hydrazines. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 84 Literaturangaben. Gefördert von: Swarnajayanti fellowship, Science and Engineering Research Board, India, Supercomputing Facility ''PARAM Shakti'' at IIT Kharagpur, established under the National Supercomputing Mission (NSM).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Unlike its other halogen atom siblings, chlorination of a bioactive compound can change its physiological characteristics, improve its pharmacological profile, and function as a point of diversification through cross‐coupling reactions. As a result, it has been a crucial strategy for drug discovery and development. However, functional groups such as amines, amides, hydroxy groups, or carboxylic acids trap the Cl + , severely limiting the reactivity and making direct chlorination far too difficult to be practical. Herein, we introduce a nucleophilic sulfonohydrazide catalyst for late‐stage halogenation of peptides and drugs. This direct, mild and metal‐free protocol shows high functional‐group tolerance and is compatible with a range of structurally diverse peptides, drugs and aromatic compounds. Furthermore, DFT studies indicate that the reaction most likely proceeds via a cationic transition state. The gram‐scale synthesis, high stability and efficiency of the catalyst provide a facile route for late‐stage functionalization and intermediates for further derivatization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HalogenationHydrazinesPeptidesAmidesAmines

Stichwörter der Autor:innen

HalogenationHydrazide CatalystsLate-Stage ChlorinationOrganocatalysisPeptides

Substanzen

HydrazinesPeptidesAmidesAmines

Autor:innen und Institutionen

  • Department of Chemistry, Indian Institute of Technology Kharagpur, Kharagpur, 721302, India.

ORCID-Profile: Haripriyo Mondal, Modhu Sudan Maji

Förderung

  • Swarnajayanti fellowship, Science and Engineering Research Board, India
  • Supercomputing Facility ''PARAM Shakti'' at IIT Kharagpur, established under the National Supercomputing Mission (NSM)

Zitieren

APA

Mondal, H., Patra, S., Saha, S., Nayak, T., Sengupta, U., & Sudan Maji, M. (2023). Late‐Stage Halogenation of Peptides, Drugs and (Hetero)aromatic Compounds with a Nucleophilic Hydrazide Catalyst. Angewandte Chemie International Edition, 62(51). https://doi.org/10.1002/anie.202312597

Vancouver

Mondal H, Patra S, Saha S, Nayak T, Sengupta U, Sudan Maji M. Late‐Stage Halogenation of Peptides, Drugs and (Hetero)aromatic Compounds with a Nucleophilic Hydrazide Catalyst. Angewandte Chemie International Edition. 2023;62(51). doi:10.1002/anie.202312597

BibTeX
@article{Mondal2023,
  author = {Mondal, Haripriyo and Patra, Subimal and Saha, Shuvendu and Nayak, Tarak and Sengupta, Uddalak and Sudan Maji, Modhu},
  title = {Late‐Stage Halogenation of Peptides, Drugs and (Hetero)aromatic Compounds with a Nucleophilic Hydrazide Catalyst},
  journal = {Angewandte Chemie International Edition},
  year = {2023},
  volume = {62},
  number = {51},
  doi = {10.1002/anie.202312597}
}
Kostenlos starten →